S&P 500

5.346,99

-0,11%

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Angiotech Pharmaceuticals - Common Shares (MM) (ANPI)
Angiotech Pharmaceuticals - Common Shares (MM) (ANPI) Notícias

ANPI

Angiotech Pharmaceuticals - Common Shares (MM) (ANPI)

Angiotech Pharmaceuticals - Common Shares (MM)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:ANPI

1 2 3 4 5 6 7 8 9 10 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
13/01/2011	15:00	PR Newswire (US)	ANGIOTECH PHARMACEUTICALS ANNOUNCES DELISTING FROM THE NASDAQ STOCK MARKET AND TRANSFER TO OTCQB™ MARKETPLACE	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
12/01/2011	18:00	PR Newswire (US)	Angiotech Pharmaceuticals, Inc. Announces Agreement with Consenting Noteholders to Extend Certain Deadlines under Support Agreem	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
06/01/2011	20:26	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
05/01/2011	23:00	PR Newswire (US)	ANGIOTECH PHARMACEUTICALS ANNOUNCES NOTICE OF DELISTING FROM THE NASDAQ STOCK MARKET	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
22/12/2010	17:30	PR Newswire (US)	Angiotech Pharmaceuticals, Inc. Announces Agreement to Extend Cure Period Under Subordinated Note Indenture	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
02/12/2010	15:18	PR Newswire (US)	Angiotech Pharmaceuticals, Inc. Announces Preliminary Injunction Ruling In Connection With Rex Medical L.P. Litigation	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
29/11/2010	15:30	PR Newswire (US)	ANGIOTECH PHARMACEUTICALS ANNOUNCES PRIVATE LABEL PRODUCT SUPPLY AGREEMENT WITH HOLOGIC	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
24/11/2010	17:15	PR Newswire (US)	Angiotech Pharmaceuticals, Inc. Announces Commencement of Proceedings by Rex Medical LP	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
16/11/2010	20:08	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
09/11/2010	08:00	PR Newswire (US)	ANGIOTECH PHARMACEUTICALS, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2010	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
29/10/2010	22:00	PR Newswire (US)	Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
29/10/2010	22:00	PR Newswire (US)	Angiotech Pharmaceuticals, Inc. Announces a Strongly Supported Transaction Agreement with Majority of Senior Subordinated Noteho	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
13/10/2010	20:00	PR Newswire (US)	ANGIOTECH PHARMACEUTICALS ANNOUNCES CONFERENCE CALL AND WEBCAST	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
06/10/2010	09:00	PR Newswire (US)	Angiotech Pharmaceuticals, Inc. Announces Commencement of Arbitration and Litigation Proceedings by QSR Holdings, Inc. Against t	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
01/10/2010	09:00	PR Newswire (US)	Angiotech Pharmaceuticals, Inc. Defers Interest Payments Under Senior Subordinated Notes. Angiotech Conducting Discussions With	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
24/09/2010	12:30	PR Newswire (US)	ANGIOTECH ANNOUNCES THAT COOK MEDICAL'S ZILVER(R) PTX(R) DRUG-ELUTING STENT MEETS ITS PRIMARY ENDPOINT IN A 479-PATIENT, MULTI-C	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
23/09/2010	15:30	PR Newswire (US)	ANGIOTECH PHARMACEUTICALS AND PARTNER ATHERSYS ANNOUNCE UPDATED RESULTS FROM PHASE I STUDY OF MULTISTEM(R) IN HEART ATTACK PATIE	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
22/09/2010	15:45	PR Newswire (US)	ANGIOTECH ANNOUNCES STRONG OUTCOMES IN DIABETIC PATIENTS TREATED WITH BOSTON SCIENTIFIC CORPORATION'S PLATINUM CHROMIUM TAXUS(R)	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
22/09/2010	15:45	PR Newswire (US)	ANGIOTECH ANNOUNCES LONG-TERM DATA SHOW ADVANTAGES FOR TAXUS(R) LIBERTÉ(R) STENT IN SMALL VESSELS AND LONG LESIONS	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
09/08/2010	17:40	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
09/08/2010	17:31	Dow Jones News	UPDATE:FDA Warns About Long-Term Problems With Blood-Clot Device	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
09/08/2010	16:22	Dow Jones News	FDA Warns About Long-Term Problems With Blood-Clot Device	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
30/07/2010	09:00	PR Newswire (US)	Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
28/07/2010	17:23	PR Newswire (US)	Angiotech Pharmaceuticals and partner Athersys announce positive results from phase I study of MultiStem(R) in heart attack pati	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
08/07/2010	14:00	PR Newswire (US)	Angiotech Pharmaceuticals announces notice of failure to satisfy a continued listing rule with The Nasdaq Stock Market.	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
24/06/2010	14:00	PR Newswire (US)	Angiotech Pharmaceuticals Announces Conference Call and Webcast	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
16/06/2010	07:03	Edgar (US Regulatory)	Proxy Statement (definitive) (DEF 14A)	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
11/06/2010	14:00	PR Newswire (US)	Angiotech's licensee, Cook Medical, files PMA submission for FDA approval of Zilver(R) PTX(R) Drug-Eluting Stent platform	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
10/06/2010	19:30	PR Newswire (US)	Angiotech Pharmaceuticals announces acceptance of 2010 medical design excellence award for Quill(TM) SRS	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
10/06/2010	15:00	PR Newswire (US)	Angiotech Pharmaceuticals announces European launch and first implants of Boston Scientific Corporation's platinum chromium TAXU	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)